These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 21854342)

  • 21. Inhaled mometasone furoate reduces oral prednisone usage and improves lung function in severe persistent asthma.
    Karpel JP; Nayak A; Lumry W; Craig TJ; Kerwin E; Fish JE; Lutsky B
    Respir Med; 2007 Mar; 101(3):628-37. PubMed ID: 16875813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mometasone furoate dry powder inhaler: a once-daily inhaled corticosteroid for the treatment of persistent asthma.
    Karpel JP; Nelson H
    Curr Med Res Opin; 2007 Nov; 23(11):2897-911. PubMed ID: 17922978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Once-daily evening administration of mometasone furoate in asthma treatment initiation.
    Bensch GW; Prenner B; Berkowitz R; Galant S; Ramsdell J; Lutsky B
    Ann Allergy Asthma Immunol; 2006 Apr; 96(4):533-40. PubMed ID: 16680923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adrenal suppression in asthmatic children receiving low-dose inhaled budesonide: comparison between dry powder inhaler and pressurized metered-dose inhaler attached to a spacer.
    Goldberg S; Einot T; Algur N; Schwartz S; Greenberg AC; Picard E; Virgilis D; Kerem E
    Ann Allergy Asthma Immunol; 2002 Dec; 89(6):566-71. PubMed ID: 12487221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthma.
    Fish JE; Karpel JP; Craig TJ; Bensch GW; Noonan M; Webb DR; Silverman B; Schenkel EJ; Rooklin AR; Ramsdell JW; Nathan R; Leflein JG; Grossman J; Graft DF; Gower RG; Garay SM; Frigas E; Degraff AC; Bronsky EA; Bernstein DI; Berger W; Shneyer L; Nolop KB; Harrison JE
    J Allergy Clin Immunol; 2000 Nov; 106(5):852-60. PubMed ID: 11080706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mometasone furoate (MF) improves lung function in pediatric asthma: A double-blind, randomized controlled dose-ranging trial of MF metered-dose inhaler.
    Amar NJ; Shekar T; Varnell TA; Mehta A; Philip G
    Pediatr Pulmonol; 2017 Mar; 52(3):310-318. PubMed ID: 27740721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative clinical pharmacology of mometasone furoate, fluticasone propionate and fluticasone furoate.
    Daley-Yates PT; Deans A; Mehta R; Sousa AR
    Pulm Pharmacol Ther; 2022 Dec; 77():102171. PubMed ID: 36243386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
    Murphy K; Noonan M; Silkoff PE; Uryniak T
    Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of mometasone furoate dry powder inhaler and fluticasone propionate dry powder inhaler in patients with moderate to severe persistent asthma requiring high-dose inhaled corticosteroid therapy: findings from a noninferiority trial.
    Harnest U; Price D; Howes T; Sussman G
    J Asthma; 2008 Apr; 45(3):215-20. PubMed ID: 18415829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bronchodilation with mometasone furoate/formoterol fumarate administered by metered-dose inhaler with and without a spacer in children with persistent asthma.
    Berger WE; Bensch GW; Weinstein SF; Skoner DP; Prenner BM; Shekar T; Nolte H; Teper AA
    Pediatr Pulmonol; 2014 May; 49(5):441-50. PubMed ID: 24019197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of mometasone furoate administered via a dry powder inhaler once daily in the evening on nocturnal lung function and sleep parameters in patients with moderate persistent asthma: a randomized, double-blind, placebo-controlled pilot study.
    Krouse JH; Krouse HJ; Janisse JJ
    Clin Drug Investig; 2009; 29(1):51-8. PubMed ID: 19067474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adrenal suppression with dry powder formulations of fluticasone propionate and mometasone furoate.
    Fardon TC; Lee DK; Haggart K; McFarlane LC; Lipworth BJ
    Am J Respir Crit Care Med; 2004 Nov; 170(9):960-6. PubMed ID: 15184207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy, safety, and tolerability of mometasone furoate in adult Japanese patients with mild asthma: open-label clinical trial findings.
    Tohda Y; Miyamoto T
    Curr Med Res Opin; 2010 Jan; 26(1):203-12. PubMed ID: 19921960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler.
    Bernstein DI; Berkowitz RB; Chervinsky P; Dvorin DJ; Finn AF; Gross GN; Karetzky M; Kemp JP; Laforce C; Lumry W; Mendelson LM; Nelson H; Pearlman D; Rachelefsky G; Ratner P; Repsher L; Segal AT; Selner JC; Settipane GA; Wanderer A; Cuss FM; Nolop KB; Harrison JE
    Respir Med; 1999 Sep; 93(9):603-12. PubMed ID: 10542973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of the long-term safety of inhaled ciclesonide on growth in children with asthma.
    Skoner DP; Maspero J; Banerji D;
    Pediatrics; 2008 Jan; 121(1):e1-14. PubMed ID: 18070931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of intranasal triamcinolone acetonide and intranasal fluticasone propionate on short-term bone growth and HPA axis in children with allergic rhinitis.
    Skoner DP; Gentile D; Angelini B; Kane R; Birdsall D; Banerji D
    Ann Allergy Asthma Immunol; 2003 Jan; 90(1):56-62. PubMed ID: 12546339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dose-dependent effects of inhaled mometasone furoate on airway function and inflammation after allergen inhalation challenge.
    Inman MD; Watson RM; Rerecich T; Gauvreau GM; Lutsky BN; Stryszak P; O'Byrne PM
    Am J Respir Crit Care Med; 2001 Aug; 164(4):569-74. PubMed ID: 11520717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label study.
    Price D; Robertson A; Bullen K; Rand C; Horne R; Staudinger H
    BMC Pulm Med; 2010 Jan; 10():1. PubMed ID: 20051135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of budesonide by means of the Turbuhaler on the hypothalmic-pituitary-adrenal axis in asthmatic subjects: a dose-response study.
    Aaronson D; Kaiser H; Dockhorn R; Findlay S; Korenblat P; Thorsson L; Källén A
    J Allergy Clin Immunol; 1998 Mar; 101(3):312-9. PubMed ID: 9525445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of mometasone, fluticasone, and montelukast on bone mineral density in adults with asthma.
    Maspero J; Backer V; Yao R; Staudinger H; Teper A
    J Allergy Clin Immunol Pract; 2013; 1(6):649-55.e1. PubMed ID: 24565713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.